2021/03/30 by Toshihiro Nishizawa, Shuntaro Yoshida, Akira Toyoshima +8
Medicine · #Colorectal Cancer Screening and Detection #Gastric Cancer Management and Outcomes #Gastrointestinal Bleeding Diagnosis and Treatment
paper · doi:10.3748/wjg.v27.i13.1321
openalex publication_date 2021/03/30 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
BACKGROUND: the ''serrated neoplastic pathway''. The clinical features of SSLs are tumor size (> 5 mm), location in the proximal colon, coverage with abundant mucus called the ''mucus cap'', indistinct borders, and a cloud-like surface. The features in magnifying narrow-band imaging are varicose microvascular vessels and expanded crypt openings. However, accurate diagnosis is often difficult. AIM: To develop a diagnostic score system for SSLs. METHODS: We retrospectively reviewed consecutive patients who underwent endoscopic resection during colonoscopy at the Toyoshima endoscopy clinic. We collected data on serrated polyps diagnosed by endoscopic or pathological examination. The significant factors for the diagnosis of SSLs were assessed using logistic regression analysis. Each item that was significant in multivariate analysis was assigned 1 point, with the sum of these points defined as the endoscopic SSL diagnosis score. The optimal cut-off value of the endoscopic SSL diagnosis score was determined by receiver-operating characteristic curve analysis. RESULTS: < 0.001). CONCLUSION: Size > 5 mm, mucus cap, and indistinct borders were significant endoscopic features for the diagnosis of SSLs. Serrated polyps with these three features should be removed during colonoscopy.